Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Blood clot preventive drugs are drugs that prevent the coagulation process by influencing certain coagulation factors. They can be used to prevent and treat diseases of intravascular embolism or thrombosis, and prevent stroke or other thrombotic diseases.
Thrombosis is the process of blood clots forming in arteries or veins. In this kind of thrombosis, the clot blocks the blood flow in the affected area and may cause serious complications, such as myocardial infarction, stroke, atherosclerotic plaque, etc. However, the use of blood clot preventive drugs can cause side effects, and people's lack of knowledge and awareness about venous thromboembolism leads to insufficient awareness of blood clot preventive drugs, which will hinder the growth of the blood clot preventive drugs market to a certain extent.
The increase in the incidence of venous thromboembolism, obesity, and the incidence of stroke, pulmonary embolism and other genetic-related diseases are the main factors driving the growth of this market during the forecast period. The increase in people's health awareness and the enhancement in disposable income are other factors that promote the growth of the blood clot preventive drugs market.
The report details the trend, potential and market size of Blood Clot Preventive Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Blood Clot Preventive Drugsmarket, defines the market attractiveness level of Blood Clot Preventive Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Blood Clot Preventive Drugs industry, describes the types of Blood Clot Preventive Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Blood Clot Preventive Drugs market and the development prospects and opportunities of Blood Clot Preventive Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Blood Clot Preventive Drugs market in Chapter 13.
By Player:
Portola Pharmaceuticals
Daiichi Sankyo Company
Bayer
Janssen Pharmaceutical
Boehringer Ingelheim
Pfizer
Bristol- Meyers Squibb
By Type:
Anticoagulants
Fibrinolytics
Anti-Platelet Drugs
Other
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Mail Order Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Blood Clot Preventive Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Blood Clot Preventive Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Blood Clot Preventive Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Blood Clot Preventive Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Blood Clot Preventive Drugs Market Analysis and Outlook to 2022
-
7.1 Global Blood Clot Preventive Drugs Consumption (2017-2022)
-
7.2 United States Blood Clot Preventive Drugs Consumption (2017-2022)
-
7.3 Europe Blood Clot Preventive Drugs Consumption (2017-2022)
-
7.4 China Blood Clot Preventive Drugs Consumption (2017-2022)
-
7.5 Japan Blood Clot Preventive Drugs Consumption (2017-2022)
-
7.6 India Blood Clot Preventive Drugs Consumption (2017-2022)
-
7.7 South Korea Blood Clot Preventive Drugs Consumption (2017-2022)
8 Region and Country-wise Blood Clot Preventive Drugs Market Analysis and Outlook to 2028
-
8.1 Global Blood Clot Preventive Drugs Consumption Forecast (2022-2028)
-
8.2 United States Blood Clot Preventive Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Blood Clot Preventive Drugs Consumption Forecast (2022-2028)
-
8.4 China Blood Clot Preventive Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Blood Clot Preventive Drugs Consumption Forecast (2022-2028)
-
8.6 India Blood Clot Preventive Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Blood Clot Preventive Drugs Consumption Forecast (2022-2028)
9 Global Blood Clot Preventive Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Blood Clot Preventive Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anticoagulants Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Fibrinolytics Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anti-Platelet Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Blood Clot Preventive Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Mail Order Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Blood Clot Preventive Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Blood Clot Preventive Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Fibrinolytics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anti-Platelet Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Blood Clot Preventive Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Mail Order Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Blood Clot Preventive Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Blood Clot Preventive Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Blood Clot Preventive Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Blood Clot Preventive Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Blood Clot Preventive Drugs Market Competitive Analysis
-
14.1 Portola Pharmaceuticals
-
14.1.1 Portola Pharmaceuticals Company Details
-
14.1.2 Portola Pharmaceuticals Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Portola Pharmaceuticals Blood Clot Preventive Drugs Product and Service
-
14.2 Daiichi Sankyo Company
-
14.2.1 Daiichi Sankyo Company Company Details
-
14.2.2 Daiichi Sankyo Company Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Daiichi Sankyo Company Blood Clot Preventive Drugs Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Blood Clot Preventive Drugs Product and Service
-
14.4 Janssen Pharmaceutical
-
14.4.1 Janssen Pharmaceutical Company Details
-
14.4.2 Janssen Pharmaceutical Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Pharmaceutical Blood Clot Preventive Drugs Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim Blood Clot Preventive Drugs Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Blood Clot Preventive Drugs Product and Service
-
14.7 Bristol- Meyers Squibb
-
14.7.1 Bristol- Meyers Squibb Company Details
-
14.7.2 Bristol- Meyers Squibb Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol- Meyers Squibb Blood Clot Preventive Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Blood Clot Preventive Drugs
-
Figure Blood Clot Preventive Drugs Picture
-
Table Global Blood Clot Preventive Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Blood Clot Preventive Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Blood Clot Preventive Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Blood Clot Preventive Drugs Consumption by Country (2017-2022)
-
Figure United States Blood Clot Preventive Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Blood Clot Preventive Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Blood Clot Preventive Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Blood Clot Preventive Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Blood Clot Preventive Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Blood Clot Preventive Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Clot Preventive Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Blood Clot Preventive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Blood Clot Preventive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Blood Clot Preventive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Blood Clot Preventive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Blood Clot Preventive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Blood Clot Preventive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Global Fibrinolytics Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Platelet Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Mail Order Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fibrinolytics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Platelet Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mail Order Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Blood Clot Preventive Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Blood Clot Preventive Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Portola Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Portola Pharmaceuticals Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Portola Pharmaceuticals Blood Clot Preventive Drugs Product and Service
-
Table Daiichi Sankyo Company (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Company Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Company Blood Clot Preventive Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Blood Clot Preventive Drugs Product and Service
-
Table Janssen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceutical Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceutical Blood Clot Preventive Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Blood Clot Preventive Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Blood Clot Preventive Drugs Product and Service
-
Table Bristol- Meyers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol- Meyers Squibb Blood Clot Preventive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol- Meyers Squibb Blood Clot Preventive Drugs Product and Service
-
